Study population
The study flow is shown in Figure Study flow chart. Demographic characteristics. Percentages do not always add up to 100% because of rounding.One subject received unblinded treatment with AK0529 (2 mg/kg bid) on a compassionate use basis and was excluded from the full analysis population.Baseline Wang respiratory score and viral load in the groups treated with different doses of AK0529 or placebo.